Devan Kansagara

InstitutionVA Portland Health Care System
AddressPortland
Oregon
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 17 Covid-19 publications, with a maximum of 2 publications in May 2020 and June 2020 and October 2020 and December 2020 and March 2021
    All Publications
    Bar chart showing 65 publications over 13 distinct years, with a maximum of 12 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Qaseem A, Yost J, Forciea MA, Jokela JA, Miller MC, Obley A, Humphrey LL, Centor RM, Andrews R, Bledsoe TA, Haeme R, Kansagara DL, Marcucci M. The Development of Living, Rapid Practice Points: Summary of Methods From the Scientific Medical Policy Committee of the American College of Physicians. Ann Intern Med. 2021 08; 174(8):1126-1132. PMID: 34029483.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    2. Mackey K, Kansagara D, Vela K. Update Alert 8: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults. Ann Intern Med. 2021 Jun; 174(6):W54-W55. PMID: 33900794.
      Citations:    Fields:    
    3. Ayers CK, Kondo KK, Williams BE, Kansagara D, Advani SM, Smith M, Young S, Saha S. Disparities in H1N1 Vaccination Rates: a Systematic Review and Evidence Synthesis to Inform COVID-19 Vaccination Efforts. J Gen Intern Med. 2021 06; 36(6):1734-1745. PMID: 33791935.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    4. Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, Forciea MA, Abraham GM, Miller MC, Obley AJ, Humphrey LL, Centor RM, Akl EA, Andrews R, Bledsoe TA, Haeme R, Kansagara DL. What Is the Antibody Response and Role in Conferring Natural Immunity After SARS-CoV-2 Infection? Rapid, Living Practice Points From the American College of Physicians (Version 1). Ann Intern Med. 2021 06; 174(6):828-835. PMID: 33721518.
      Citations:    Fields:    Translation:Humans
    5. Mackey K, Kansagara D, Vela K. Update Alert 7: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults. Ann Intern Med. 2021 02; 174(2):W25-W29. PMID: 33395346.
      Citations: 3     Fields:    
    6. Mackey K, Kansagara D, Vela K. Update Alert 6: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults. Ann Intern Med. 2021 01; 174(1):W17. PMID: 33253036.
      Citations:    Fields:    Translation:Humans
    7. Mackey K, Ayers CK, Kondo KK, Saha S, Advani SM, Young S, Spencer H, Rusek M, Anderson J, Veazie S, Smith M, Kansagara D. Racial and Ethnic Disparities in COVID-19-Related Infections, Hospitalizations, and Deaths : A Systematic Review. Ann Intern Med. 2021 03; 174(3):362-373. PMID: 33253040.
      Citations: 87     Fields:    Translation:HumansPHPublic Health
    8. Mackey K, Kansagara D, Vela K. Update Alert 5: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults. Ann Intern Med. 2020 12 15; 173(12):167-168. PMID: 33105094.
      Citations:    Fields:    Translation:Humans
    9. Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, Abraham GM, Jokela JA, Forciea MA, Miller MC, Humphrey LL, Centor RM, Andrews R, Haeme R, Kansagara DL, Marcucci M. Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 1). Ann Intern Med. 2021 02; 174(2):229-236. PMID: 33017175.
      Citations: 1     Fields:    Translation:Humans
    10. Mackey K, Kansagara D, Vela K. Update Alert 4: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults. Ann Intern Med. 2020 11 03; 173(9):W147-W148. PMID: 32956599.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    11. Mackey K, Kansagara D, Vela K. Update Alert 3: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults. Ann Intern Med. 2020 10 06; 173(7):130-131. PMID: 32845705.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    12. Mackey K, Kansagara D, Vela K. Update Alert 2: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults. Ann Intern Med. 2020 09 01; 173(5):W87. PMID: 32701362.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    13. Kansagara D, Mackey K, Vela K. Update Alert: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults. Ann Intern Med. 2020 08 04; 173(3):W66. PMID: 32584593.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    14. Qaseem A, Etxeandia-Ikobaltzeta I, Yost J, Miller MC, Abraham GM, Obley AJ, Forciea MA, Jokela JA, Humphrey LL, Centor RM, Andrews R, Bledsoe TA, Haeme R, Kansagara DL, Marcucci M. Use of N95, Surgical, and Cloth Masks to Prevent COVID-19 in Health Care and Community Settings: Living Practice Points From the American College of Physicians (Version 1). Ann Intern Med. 2020 10 20; 173(8):642-649. PMID: 32551813.
      Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
    15. Mackey K, King VJ, Gurley S, Kiefer M, Liederbauer E, Vela K, Sonnen P, Kansagara D. Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults: A Living Systematic Review. Ann Intern Med. 2020 08 04; 173(3):195-203. PMID: 32422062.
      Citations: 64     Fields:    Translation:HumansCellsPHPublic Health
    16. Qaseem A, Yost J, Etxeandia-Ikobaltzeta I, Miller MC, Abraham GM, Obley AJ, Forciea MA, Jokela JA, Humphrey LL, Centor RM, Andrews R, Bledsoe TA, Haeme R, Kansagara DL, Marcucci M. Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians (Version 1). Ann Intern Med. 2020 07 21; 173(2):137-142. PMID: 32422063.
      Citations: 13     Fields:    Translation:HumansCells
    Kansagara's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (110)
    Explore
    _
    Co-Authors (36)
    Explore
    _
    Similar People (60)
    Explore
    _